Amlodipine And Atorvastatin Tablet, Film Coated
Product Images NDC 62332-764

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Amlodipine And Atorvastatin (NDC 62332-764). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amloatorva-10-10 (Amloatorva 10 10)

Label for Amlodipine and Atorvastatin Tablets, USP, strength 10 mg/10 mg, film-coated tablets in a bottle of 30. Manufactured by Alembic Pharmaceuticals Limited, India, and for Alembic Pharmaceuticals, Inc., USA. The label includes storage instructions, barcode, and Rx only designation.*

FDA Label Image

Amloatorva-10-20 (Amloatorva 10 20)

Label for Amlodipine and Atorvastatin Tablets USP, 10 mg/20 mg strength, film-coated oral tablets. The package contains 30 tablets and is labeled for prescription use only (Rx only). Manufactured by Alembic Pharmaceuticals Limited in India and for Alembic Pharmaceuticals, Inc. in the USA. The label includes storage instructions, barcode, and lot/expiry details.*

FDA Label Image

Amloatorva-10-40 (Amloatorva 10 40)

Label for Amlodipine and Atorvastatin Tablets, USP with strength 10 mg/40 mg. The film-coated tablets come in a package of 30, labeled Rx only, manufactured by Alembic Pharmaceuticals Limited, Gujarat, India, and Alembic Pharmaceuticals, Inc., New Jersey, USA. The label includes storage instructions and a barcode.*

FDA Label Image

Amloatorva-10-80 (Amloatorva 10 80)

Label for Amlodipine and Atorvastatin Tablets, USP 10 mg/80 mg film-coated tablets. The label indicates 30 tablets per package, manufactured by Alembic Pharmaceuticals Limited in India for Alembic Pharmaceuticals, Inc. in the USA. Storage instructions specify controlled room temperature and protected from light and moisture. Includes NDC 62332-765-30 and barcode information.*

FDA Label Image

Amloatorva-25-10 (Amloatorva 25 10)

Label for Amlodipine and Atorvastatin Tablets, USP 2.5 mg/10 mg film-coated tablets. The package contains 30 tablets, labeled Rx only. Manufactured by Alembic Pharmaceuticals Limited in Gujarat, India, and for Alembic Pharmaceuticals, Inc. in Bedminster, NJ. The label includes storage instructions and a barcode with NDC 62332-755-30.*

FDA Label Image

Amloatorva-25-20 (Amloatorva 25 20)

Label for Amlodipine and Atorvastatin Tablets, USP, 2.5 mg/20 mg film-coated oral tablets. The package contains 30 tablets and is labeled Rx only. Manufactured by Alembic Pharmaceuticals Limited, Gujarat, India, and for Alembic Pharmaceuticals, Inc., New Jersey, USA. The label includes NDC 62332-756-30 and storage instructions.*

FDA Label Image

Amloatorva-25-40 (Amloatorva 25 40)

Label for Amlodipine and Atorvastatin Tablets, USP 2.5 mg/40 mg by Alembic Pharmaceuticals Inc. The film-coated oral tablets are supplied in a package of 30. The label includes dosing information, manufacturing details, storage instructions, a barcode, and identifiers including NDC 62332-757-30.*

FDA Label Image

Amloatorva-5-10 (Amloatorva 5 10)

Amlodipine and Atorvastatin Tablets, USP 5 mg/10 mg film-coated tablets, packaged in a container of 30 tablets. The label includes active ingredient amounts, manufacturer Alembic Pharmaceuticals Limited (India), and Alembic Pharmaceuticals, Inc. (USA). It shows storage instructions, an NDC code, and a barcode.*

FDA Label Image

Amloatorva-5-20 (Amloatorva 5 20)

Label for Amlodipine and Atorvastatin Tablets, USP, 5 mg/20 mg strength. The film-coated tablets are prescription-only, packaged as 30 tablets, and manufactured by Alembic Pharmaceuticals Limited in India for Alembic Pharmaceuticals, Inc. USA. The label includes storage instructions, barcode, NDC number 62332-759-30, and GTIN barcode details.*

FDA Label Image

Amloatorva-5-40 (Amloatorva 5 40)

Label for Amlodipine and Atorvastatin Tablets, USP containing 5 mg of amlodipine and 40 mg of atorvastatin. The package contains 30 film-coated tablets. Manufactured by Alembic Pharmaceuticals Limited in Gujarat, India, and for Alembic Pharmaceuticals, Inc., NJ, USA. Label includes storage instructions and a barcode.*

FDA Label Image

Amloatorva-5-80 (Amloatorva 5 80)

Label for Amlodipine and Atorvastatin Tablets, USP, containing 5 mg amlodipine and 80 mg atorvastatin. The film-coated tablets are packaged in a bottle of 30 tablets. Manufactured by Alembic Pharmaceuticals Limited in Gujarat, India, and for Alembic Pharmaceuticals, Inc. in New Jersey, USA. Label includes storage instructions and barcode.*

FDA Label Image

Amloatorva-amlodipine.jpg (Amloatorva Amlodipine)

Chemical structure of Amlodipine and Atorvastatin components. The image shows the molecular formulas representing the active ingredients as identified in the product data for the combination drug Amlodipine and Atorvastatin.*

FDA Label Image

Amloatorva-atorvastatin.jpg (Amloatorva Atorvastatin)

Chemical structure of Amlodipine and Atorvastatin, showing the molecular arrangement with phenyl groups, hydroxyl groups, and calcium ion complex with water molecules (Ca2+ · 3 H2O) as part of the atorvastatin calcium salt form.*

FDA Label Image

Figure 1 (Amloatorva Fig 1)

A line graph depicting event rate over time in months, comparing Amlodipine with a placebo. The x-axis ranges from 0 to 24 months, and the y-axis shows event rates from 0 to 0.25. Two curves are labeled 'Amlodipine' and 'Placebo,' with number at risk indicated below the timeline starting at 1318 subjects.*

FDA Label Image

Amloatorva-fig3.jpg (Amloatorva Fig3)

A line chart depicting cumulative incidence percentage over time in years, comparing Atorvastatin (solid line) versus Placebo (dashed line). The graph shows that Atorvastatin has a lower cumulative incidence than Placebo over a period of up to 3.5 years, with a hazard ratio (HR) of 0.64 (95% CI 0.5 to 0.83) and a p-value of 0.0005.*

FDA Label Image

Amloatorva-fig4.jpg (Amloatorva Fig4)

A Kaplan-Meier cumulative hazard curve comparing Atorvastatin versus placebo over a four-year follow-up period. The y-axis shows cumulative hazard percentage, and the x-axis depicts time to first primary endpoint in years. The graph includes hazard ratio data (HR 0.63, 95% CI 0.48 to 0.83, p=0.001) indicating lower risk with Atorvastatin.*

FDA Label Image

Amloatorva-fig5.jpg (Amloatorva Fig5)

A line graph comparing the percentage of subjects experiencing the first major cardiovascular event over five years for Atorvastatin 10 mg (dashed line) and Atorvastatin 80 mg (solid line). The x-axis represents time in years, and the y-axis represents the percentage of subjects. The graph includes a hazard ratio of 0.78 with a statistical significance of P=0.0002, indicating fewer events in the 80 mg group.*

FDA Label Image

Amloatorva-figure-2.jpg (Amloatorva Figure 2)

A forest plot depicting hazard ratios with 95% confidence intervals for the comparison of Amlodipine versus placebo across various patient subgroups, including overall patients, age groups (<65 and ≥65), gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata. The plot visually indicates effect favoring either Amlodipine or placebo along a hazard ratio axis ranging from 0 to 2.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.